ArticleTransactions of the American Ophthalmological Society1998
Correlation of quality of life with clinical symptoms and signs at the time of glaucoma diagnosis.
Article in Transactions of the American Ophthalmological Society, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 47 citations in OpenAlex.
- Qualitative Interviews to Better Understand the Patient Experience and Evaluate Patient-Reported Outcomes (PRO) in RLBP1 Retinitis Pigmentosa (RLBP1 RP).Advances in therapy · 2020Article
- Article
- Comparison of vision-related quality of life in primary open-angle glaucoma and dry-type age-related macular degeneration.Eye (London, England) · 2017Article
- Article
- A comparison of the sensitivity of EQ-5D, SF-6D and TTO utility values to changes in vision and perceived visual function in patients with primary open-angle glaucoma.BMC ophthalmology · 2012Article
- Glaucoma and reading speed: the Salisbury Eye Evaluation project.Archives of ophthalmology (Chicago, Ill. : 1960) · 2009Article
- Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study.Ophthalmology · 2008Article
- Severity of visual field loss and health-related quality of life.American journal of ophthalmology · 2007Article
- Bimatoprost: a pharmacoeconomic review of its use in open-angle glaucoma and ocular hypertension.PharmacoEconomics · 2006Review
- +Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life.Health and quality of life outcomes · 2005Article
- Quality of life in patients with Graves ophthalmopathy.Transactions of the American Ophthalmological Society · 2005Article
- Vision related quality of life and topical glaucoma treatment side effects.Health and quality of life outcomes · 2003Article
- Vision-specific instruments for the assessment of health-related quality of life and visual functioning: a literature review.PharmacoEconomics · 2002Review
- Glaucoma patients' assessment of their visual function and quality of life.Transactions of the American Ophthalmological Society · 2001Article
- Glaucoma history and risk factors.Journal of optometryReview
- Contrasting the use of 2 vision-specific quality of life questionnaires in subjects with open-angle glaucoma.Journal of glaucomaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
purposeTo examine the relationship between clinical measures of visual function and patient-reported measures of symptoms and health status in a large cohort of glaucoma patients at the time of diagnosis. SUBJECTS AND
methodsThe 607 patients in the Collaborative Initial Glaucoma Treatment Study (CIGTS) received standardized examinations of visual acuity and visual field at enrollment. In addition, they completed a health-related quality-of-life instrument, which included the Visual Activities Questionnaire (VAQ), Sickness Impact Profile (SIP), a symptom and a comorbidity chart, a question about their degree of worry about becoming blind, and many other items.
resultsThe SIP total and dimension scores correlated only weakly, and not significantly, with visual acuity and visual field measures. The VAQ total and subscale scores, particularly the peripheral vision subscale, correlated weakly and significantly with visual acuity and visual field scores, especially those from the better eye. Worry about blindness and symptoms attributed to glaucoma correlated weakly but significantly to visual field scores from the worse eye. Attempts to improve correlations by scoring the visual fields differently, including only paracentral and pericentral test locations in the scores, and simulating binocular visual field scores were largely unsuccessful.
conclusionsAt diagnosis, most patients were relatively free of glaucoma-induced impairments, so clinical measures were poor predictors of a patient's perception of health-related quality of life. The vision-specific VAQ and glaucoma-related symptom score correlated better than the generic SIP with clinical measures at the time of enrollment into CIGTS.
Indexed as
Identifiers
10360308PMC1298414W1585997711What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.